What is Regaine and how does it work?
Regaine Extra Strength Solution 5% is an effective treatment for hereditary hair loss in men. Regaine has been clinically proven to be effective in stopping further hair loss in 4 out of 5 men and encouraging hair regrowth in 3 out 5. The medication contains minoxidil as its active ingredient, which aids blood flow to the hair follicles of the scalp to increase the follicle size and hair shaft diameter. This prevents further hair loss and promotes hair regrowth.
Can I use Regaine?
Regaine 5% Solution is licensed for men up to the age of 65. Young men with thinning hair or a coin-sized patch at the top of the scalp are likely to benefit the most from this treatment. If you have been bald for years or have large patches of hair loss on your head, Regaine may not help.
How effective is Regaine?
You may start to see soft, downy hair growth in just 8 weeks, although it can take up to 12.
How long does Regaine take to work?
As hair growth is a slow process, it can take up to 8 - 12 weeks for there to be any visible improvement in hair volume.
How should I use it?
Make sure your head is dry before applying 1ml of the Regaine Solution 5% to the effected area on your scalp twice a day, every day. Massage the solution gently into your scalp. Leave at least 12 hours before the next application and do not use the solution more than twice a day.
What is the different between Regaine Extra Strength Foam 5% and Regaine Extra Strength Solution 5%?
The main difference is that Regaine 5% Foam is licensed for men with hereditary hair loss between the ages of 18 and 49 while Regaine 5% Solution is licensed for men up to the age of 65. This is due to the product's efficacy for patients and the method of action.
What are the side effects of Regaine?
Like all medications, Regaine can have some side effects, although not all patients will experience these. The most common side effect is a headache, which can affect 1 in 10 people. Others include excessive hair growth and itching.
Always read the patient information leaflet before commencing treatment.